Agenda

• Prevention Keynote: HIV Vaccine Development: How will we translate scientific opportunity into public health impact?
  Mark Feinberg, MD, PhD
• Human Monoclonal Antibodies for Pre-Exposure Prophylaxis (PrEP) of HIV-1 Infection
  John R. Mascola, MD
• Progress in Advancing Vaccine Concepts to P5 Efficacy Trials
  Julie McElrath, MD, PhD
• Defining Correlates of Protection against HIV/SIV
  Galit Alter, PhD
• Ad26 Based Vaccines for HIV and Beyond
  Dan H. Barouch, MD, PhD
• Building on Prevention: How prophylactic vaccine trials inform HIV cure
  Nicole Frahm, PhD
• Targeting HIV Where it Hurts
  Tomas Hanke, PhD, MSc
• Treatment Keynote: Barriers to a Cure and Therapy: What will a vaccine need to do to be a success?
  Louis J. Picker, MD